Quick Takeaways
- Point72 Asset Management, L.P. filed SCHEDULE 13G/A for Syros Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (SYRS).
- Disclosed ownership: 0%.
- Date of event: 31 Dec 2024.
Point72 Asset Management, L.P. - 31 Dec 2024 SCHEDULE 13G/A Report for Syros Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (SYRS)
- Filing Manager
- Point72 Asset Management, L.P.
- Reporting Manager
- Point72 Asset Management, L.P.
- Symbol
- SYRS
- Disclosed Ownership
- 496 shares
- Ownership
- 0%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Feb 2025, 16:09:05 UTC
- Date of event
- 31 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Point72 Asset Management, L.P. disclosed 0% ownership in Syros Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (SYRS) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Feb 2025, 16:09.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 0% | 496 | 0 | 496 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Point72 Capital Advisors, Inc. | 0% | 496 | 0 | 496 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Steven A. Cohen | 0% | 496 | 0 | 496 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person |